Annual ROE:
1.52%+21.44%(+107.63%)Summary
- As of today, AUPH annual return on equity is 1.52%, with the most recent change of +21.44% (+107.63%) on December 31, 2024.
- During the last 3 years, AUPH annual ROE has risen by +42.33% (+103.72%).
- AUPH annual ROE is now -99.44% below its all-time high of 271.97%, reached on November 30, 1998.
Performance
AUPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
21.42%+4.72%(+28.26%)Summary
- As of today, AUPH quarterly return on equity is 21.42%, with the most recent change of +4.72% (+28.26%) on September 30, 2025.
- Over the past year, AUPH quarterly ROE has increased by +27.41% (+457.60%).
- AUPH quarterly ROE is now -96.48% below its all-time high of 608.33%, reached on June 30, 2013.
Performance
AUPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AUPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +107.6% | +457.6% |
| 3Y3 Years | +103.7% | +176.9% |
| 5Y5 Years | +103.5% | +132.5% |
AUPH ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +103.7% | at high | +176.9% |
| 5Y | 5-Year | at high | +103.5% | at high | +132.5% |
| All-Time | All-Time | -99.4% | +100.3% | -96.5% | +103.0% |
AUPH ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | 21.42%(+28.3%) |
| Jun 2025 | - | 16.70%(+54.2%) |
| Mar 2025 | - | 10.83%(+603.2%) |
| Dec 2024 | 1.52%(+107.6%) | 1.54%(+125.7%) |
| Sep 2024 | - | -5.99%(+55.1%) |
| Jun 2024 | - | -13.35%(+18.4%) |
| Mar 2024 | - | -16.36%(+17.9%) |
| Dec 2023 | -19.92%(+18.6%) | -19.92%(-3.4%) |
| Sep 2023 | - | -19.26%(-7.8%) |
| Jun 2023 | - | -17.87%(+22.7%) |
| Mar 2023 | - | -23.13%(+6.8%) |
| Dec 2022 | -24.46%(+40.1%) | -24.81%(+10.9%) |
| Sep 2022 | - | -27.85%(+29.6%) |
| Jun 2022 | - | -39.55%(+9.4%) |
| Mar 2022 | - | -43.63%(+9.0%) |
| Dec 2021 | -40.81%(-40.4%) | -47.94%(-11.3%) |
| Sep 2021 | - | -43.08%(-2.1%) |
| Jun 2021 | - | -42.21%(-11.5%) |
| Mar 2021 | - | -37.85%(-16.7%) |
| Dec 2020 | -29.07%(+32.4%) | -32.44%(+50.8%) |
| Sep 2020 | - | -65.87%(+8.7%) |
| Jun 2020 | - | -72.15%(+2.7%) |
| Mar 2020 | - | -74.17%(+7.2%) |
| Dec 2019 | -42.99%(+6.7%) | -79.89%(-61.7%) |
| Sep 2019 | - | -49.42%(-4.1%) |
| Jun 2019 | - | -47.47%(-4.4%) |
| Mar 2019 | - | -45.45%(+1.0%) |
| Dec 2018 | -46.08%(+34.4%) | -45.91%(-30.9%) |
| Sep 2018 | - | -35.08%(-18.8%) |
| Jun 2018 | - | -29.53%(-44.0%) |
| Mar 2018 | - | -20.51%(+58.3%) |
| Dec 2017 | -70.20%(+15.8%) | -49.13%(+25.5%) |
| Sep 2017 | - | -65.93%(+19.7%) |
| Jun 2017 | - | -82.13%(+38.8%) |
| Mar 2017 | - | -134.27%(-28.6%) |
| Dec 2016 | -83.33%(-45.7%) | -104.39%(-8.8%) |
| Sep 2016 | - | -95.92%(-22.2%) |
| Jun 2016 | - | -78.52%(-26.6%) |
| Mar 2016 | - | -62.00%(+3.9%) |
| Dec 2015 | -57.19%(-0.4%) | -64.53%(-15.1%) |
| Sep 2015 | - | -56.08%(-34.5%) |
| Jun 2015 | - | -41.71%(+29.9%) |
| Mar 2015 | - | -59.46%(-7.3%) |
| Dec 2014 | -56.99%(-19.9%) | -55.44%(+2.0%) |
| Sep 2014 | - | -56.60%(+15.2%) |
| Jun 2014 | - | -66.71%(-40.4%) |
| Mar 2014 | - | -47.50%(+37.0%) |
| Dec 2013 | -47.55%(+89.4%) | -75.37%(+84.1%) |
| Sep 2013 | - | -472.86%(-177.7%) |
| Jun 2013 | - | 608.33%(+185.7%) |
| Mar 2013 | - | -709.98%(-140.1%) |
| Dec 2012 | -449.50% | -295.65%(-68.6%) |
| Sep 2012 | - | -175.40%(-102.4%) |
| Jun 2012 | - | -86.67%(-2299.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | 3.94%(+115.4%) |
| Dec 2011 | -38.76%(+61.0%) | -25.63%(-159.5%) |
| Sep 2011 | - | 43.11%(+243.9%) |
| Jun 2011 | - | -29.95%(+76.8%) |
| Mar 2011 | - | -129.34%(-31.5%) |
| Dec 2010 | -99.29%(+10.6%) | -98.34%(+14.0%) |
| Sep 2010 | - | -114.33%(-42.4%) |
| Jun 2010 | - | -80.26%(-1.9%) |
| Mar 2010 | - | -78.75%(+30.7%) |
| Dec 2009 | -111.07%(-11.2%) | -113.65%(+5.8%) |
| Sep 2009 | - | -120.67%(-8.0%) |
| Jun 2009 | - | -111.75%(+10.5%) |
| Mar 2009 | - | -124.87%(-21.8%) |
| Dec 2008 | -99.87%(+22.0%) | -102.49%(-5.7%) |
| Sep 2008 | - | -96.96%(-7.1%) |
| Jun 2008 | - | -90.51%(-5.8%) |
| Mar 2008 | - | -85.51%(+5.5%) |
| Dec 2007 | -128.12%(-70.0%) | -90.49%(-6.1%) |
| Sep 2007 | - | -85.25%(-1.2%) |
| Jun 2007 | - | -84.20%(-10.0%) |
| Mar 2007 | - | -76.57%(-5.6%) |
| Dec 2006 | -75.38%(-27.8%) | -72.51%(-14.0%) |
| Sep 2006 | - | -63.59%(-3.5%) |
| Jun 2006 | - | -61.46%(-3.8%) |
| Mar 2006 | - | -59.21%(+1.8%) |
| Dec 2005 | -58.99%(-71.5%) | -60.31%(-6.1%) |
| Sep 2005 | - | -56.84%(-3.0%) |
| Jun 2005 | - | -55.16%(-23.5%) |
| Mar 2005 | - | -44.66%(-28.6%) |
| Dec 2004 | -34.40%(-47.3%) | -34.74%(-15.1%) |
| Sep 2004 | - | -30.17%(-16.0%) |
| Jun 2004 | - | -26.00%(-29.3%) |
| Mar 2004 | - | -20.11%(+12.8%) |
| Dec 2003 | -23.35%(-2523.6%) | -23.06%(-26.1%) |
| Sep 2003 | - | -18.29%(-199.8%) |
| Jun 2003 | - | -6.10%(-29.2%) |
| Mar 2003 | - | -4.72%(-574.3%) |
| Dec 2002 | -0.89%(+97.2%) | -0.70%(-112.4%) |
| Sep 2002 | - | 5.65%(+172.3%) |
| Jun 2002 | - | -7.81%(+75.6%) |
| Mar 2002 | - | -32.02%(+13.8%) |
| Dec 2001 | -31.57%(+57.3%) | - |
| Dec 2001 | - | -37.15%(+20.7%) |
| Sep 2001 | - | -46.87%(+5.1%) |
| Jun 2001 | - | -49.39%(-155.6%) |
| Mar 2001 | - | -19.32%(-322.1%) |
| Dec 2000 | -73.85%(+27.4%) | - |
| Jun 2000 | - | 8.70%(-3.9%) |
| Mar 2000 | - | 9.05%(+110.6%) |
| Nov 1999 | -101.76%(-137.4%) | -85.71%(-738.2%) |
| Aug 1999 | - | 13.43%(+200.4%) |
| May 1999 | - | 4.47%(+2.1%) |
| Feb 1999 | - | 4.38% |
| Nov 1998 | 271.97% | - |
FAQ
- What is Aurinia Pharmaceuticals Inc. annual return on equity?
- What is the all-time high annual ROE for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. annual ROE year-on-year change?
- What is Aurinia Pharmaceuticals Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. quarterly ROE year-on-year change?
What is Aurinia Pharmaceuticals Inc. annual return on equity?
The current annual ROE of AUPH is 1.52%
What is the all-time high annual ROE for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high annual return on equity is 271.97%
What is Aurinia Pharmaceuticals Inc. annual ROE year-on-year change?
Over the past year, AUPH annual return on equity has changed by +21.44% (+107.63%)
What is Aurinia Pharmaceuticals Inc. quarterly return on equity?
The current quarterly ROE of AUPH is 21.42%
What is the all-time high quarterly ROE for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high quarterly return on equity is 608.33%
What is Aurinia Pharmaceuticals Inc. quarterly ROE year-on-year change?
Over the past year, AUPH quarterly return on equity has changed by +27.41% (+457.60%)